Loading Events

« All Events

Human Proteome Organization World Congress (HUPO)

October 24 - October 28

The 20th Human Proteome Organization World Congress will bring together biopharma and biotech drug developments with a theme of ‘Clinical Proteomics for the Benefit of Patients’ for the first time involving Pharma industry in one of the foremost arena for the advancements of life sciences.

We look forward to seeing you there – hopefully we will have the opportunity to see you in person.

More information on how to connect with Seer at HUPO coming soon.


October 24
October 28




Introduction card text
We look forward to seeing you at HUPO - hopefully we will have the opportunity to see you in person.

First name Last name

Title goes here

Philip Ma is the Chief Business Officer for Seer. Previously, he was Vice-President for Digital Health Technologies and Data Sciences at Biogen, a group that he established in 2015 to discover insights and create value for Biogen and its patients. Prior to joining Biogen, Philip was Senior Partner at McKinsey & Company, where he served global leaders in the pharmaceutical and biotech sectors, leading the West Coast Healthcare Practice and global Personalized Medicine practice for the Firm. Active in community affairs, Philip also serves on the Board of Committee of 100, a group of Chinese-American business and community leaders focused on U.S. China relations and the Asian-American experience. Before McKinsey, Philip was a macromolecular crystallographer in the lab of Dr. Carl O. Pabo at Massachusetts Institute of Technology, where he received his Ph.D. in Biology. Philip also has degrees in Biochemistry (A.B. from Harvard College) and in Economics (MPhil from Oxford University, where he was a Rhodes Scholar).